Tirzepatide
Peptiva
Tirzepatide
ISKLJUČIVO ZA IN VITRO LABORATORIJSKA ISTRAŽIVANJA.
Nije namijenjen osobnoj, kliničkoj, dijagnostičkoj ili veterinarskoj primjeni niti primjeni na ljudima ili životinjama.
Description and specifications
What is Tirzepatide?
Tirzepatide is a synthetic peptide that simultaneously activates GIP and GLP-1 receptors. This dual incretin activity makes it an important subject of contemporary research into glucose regulation, appetite, and energy balance.
Mechanism and Scientific Context
By binding to GIP and GLP-1 receptors, it affects glucose-dependent insulin secretion, glucagon signaling, gastric emptying, and central satiety pathways. Scientific interest focuses on how the co-activation of these receptors alters metabolic responses compared to acting solely on the GLP-1 receptor.
Main Research Areas
- glucose metabolism and insulin sensitivity
- regulation of appetite, satiety, and energy intake
- changes in body composition and lipid metabolism
- cardiometabolic indicators and liver fat
How to interpret research data?
When reading literature, verify the identity of the tested material, the type of model, and the study's limitations. The existence of a paper on a molecule does not confirm the properties of this product or its batch. Findings from laboratory and animal models do not prove clinical benefit.
Available Peptiva variants
- 10 mg · Lyophilized vial
- 10 mg · Research dispenser
- 20 mg · Lyophilized vial
- 20 mg · Research dispenser
Select the available variant and check its name, total content, and price. The photo is not a substitute for the declaration of the selected variant.
Format and packaging content
Research dispenser: the variant contains a fully pre-filled dispenser with the selected content, not just a separate replacement cartridge. The quantity stated with the variant refers to the total declared content, not the amount per individual use.
Lyophilized vial: the variant contains lyophilized material in a vial, without a dispenser. This description does not refer to bacteriostatic water or a separate empty container.
Storage and handling conditions depend on the specific formulation and batch declaration. The packaging format does not confirm sterility, dosing accuracy, stability, or suitability for human or animal application.
Important limitations
Most clinical data refer to strictly controlled protocols and approved pharmaceutical products. Research material is not a substitute for medicine or medical supervision.
Batch documentation
For inquiries about available COA documentation, please contact peptivacomhr@gmail.com with the product name and LOT number, if known. Availability and scope of analyses are checked for the specific batch. COA does not inherently prove sterility or suitability for human or animal application.
Intended use and limitations: The product is intended exclusively for laboratory research. It is not intended for human or animal use, diagnosis, treatment, mitigation, or prevention of disease. The description is not medical advice. The research-use-only label and packaging name do not by themselves determine the regulatory status of the product or prove its safety or sterility.
COA on request
To enquire about a certificate of analysis (COA), send the material name, requested variant and LOT / batch number if available. Documents are not published on this page.
Request a COA by emailThe button opens your email app with a prepared enquiry. You send the message yourself. peptivacomhr@gmail.com
A COA applies to a specific batch. A purity result alone does not establish sterility, absence of endotoxins or safety for use in humans or animals.